ArticleEuropean journal of nuclear medicine and molecular imaging2024

Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma.

Daniela Weiler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.